Assessment of the impact of a clinical and health services research call in Catalonia

Research Evaluation

Volumn 21, Issue 4, 2012, Pages 319-328

  Adam, Paula ^a,b   Solans Domènech, Maite ^a,b   Pons, Joan M V ^a,b,c   Aymerich, Marta ^c,d   Berra, Silvina ^e   Guillamon, Imma ^a,b   Sánchez, Emilia ^f   Permanyer Miralda, Gaietà ^a,b,g  

^a Catalan Agency for Health Information   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c GENERALITAT DE CATALUNYA   (Spain)

^d UNIVERSITY OF GIRONA   (Spain)

^e UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^f UNIVERSITAT RAMON LLULL   (Spain)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

clinical and health services research; funding agency; informed decision making; payback model; research impact assessment; topic prioritization

Indexed keywords

EID: 84867548000     PISSN: 09582029     EISSN: 14715449     Source Type: Journal    
DOI: 10.1093/reseval/rvs024     Document Type: Article

References (34)

1. Adam, P. et al. (2011a) Impact of Clinical and Health Services Research Projects on Decision-Making. A Qualitative Case Study. Barcelona: Catalan Agency for Health Information, Assessment and Quality, Catalan Health Service, Department of Health, Generalitat de Catalunya: 2011.
2. -. (2011b) L'impacte social de la recerca biomèdica a Catalunya. Nota d'Economia, Departament d'Economia i Finances, Generalitat de Catalunya, vol. 97-98, pp. 127-53.
3. -. (2010) Impact of Clinical and Health Services Research on Advancing Knowledge. Study Applied to the CAHTA's Research Calls. 3rd edn. Barcelona: Catalan Health Service, Department of Health, Government of Catalonia.
4. Berra, S. et al. (2010) 'Setting priorities in clinical and health services research: properties of an adapted and updated method'. International Journal of Technology Assessment in Health Care, 26/2: 217-24.
5. Brotons, C. et al. (2002) 'La influencia de los métodos de presentación de los resultados en ensayos clínicos sobre la eficacia de una intervención y la intencion de prescribir farmacos para la prevención cardiovascular', Revista Española de Cardiología, 55/10: 1042-51. (Pubitemid 35363932)
6. Carmichael, M. and Begley, S. (2011) Desperately Seeking Cures, [web on Internet] (New York, US: Newsweek Magazine, 2010) last accessed 13 September 2011.
7. Conesa, A. et al. (2003) 'Evaluación de los informes de asistencia de urgencias como instrumento de gestión de la información clínica', Medicina Clinica (Barcelona), 120/19: 734-6. (Pubitemid 36763875)
8. Conroy, R. M. et al. (2003) 'Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project', European Heart Journal, 24/11: 987-1003. (Pubitemid 36712275)
9. Dorsey, E. R. et al. (2010) 'Funding of US biomedical research, 2003-2008', The Journal of the American Medical Association, 303/2: 137-43.
10. European Science Foundation. (2011) Implementation of Medical Research in Clinical Practice. Strasbourg cedex, France: European Science Foundation.
11. Figg, W. D. et al. (2006) 'Scientific collaboration results in higher citation rates of published articles', Pharmacotherapy, 26/6: 759-67. (Pubitemid 43807627)
12. Figueredo-Gaspari, E. (2005) 'V'aloración curricular de las publicaciones científicas', Medicina Clinica (Barcelona), 125/17: 661-5. (Pubitemid 41788962)
13. Frank, C. and Nason, E. (2009) 'Health research: measuring the social, health and economic benefits', Canadian Medical Association Journal, 180/5: 528-34.
14. García-Armesto, S. et al. (2010) 'Health System Review. Brussels (Belgium): Health Systems in Transition', European Observatory on Health Systems and Policies, 4: 1-295.
15. Garcia-Aymerich, J. et al. (2001) 'Risk Factors for Hospitalization for a Chronic Obstructive Pulmonary Disease Exacerbation. EFRAM Study', American Journal of Respiratory and Critical Care Medicine, 164/6: 1002-7. (Pubitemid 32971648)
16. Hanney, S. et al. (2007) 'An assessment of the impact of the NHS Health Technology Assessment Programme', Health Technology Assessment, 11/53: iii-xi, 1.
17. Hanney, S. R. et al. (2004) 'Proposed Methods for Reviewing the Outcomes of Health Research: The Impact of Funding by the UK's 'Arthritis Research Campaign', Health Research Policy and Systems, 2/1: 4.
18. Johnstone, C. N. et al. (2005) 'PRR5 Encodes a Conserved Proline-Rich Protein Predominant in Kidney: Analysis of Genomic Organization, Expression, and Mutation Status in Breast and Colorectal Carcinomas', Genomics, 85/3: 338-51. (Pubitemid 40249426)
19. Kwan, P. et al. (2007) 'A Systematic Evaluation of Payback of Publicly Funded Health and Health Services Research in Hong Kong', BMC Health Services Research, 7: 121.
20. Llovet, J. M. et al. (2001) 'Increased Risk of Tumor Seeding After Percutaneous Radiofrequency Ablation for Single Hepatocellular Carcinoma', Hepatology, 33/5: 1124-9. (Pubitemid 32378211)
21. Martinez, E. et al. (2003) 'Substitution of Nevirapine, Efavirenz, or Abacavir for Protease Inhibitors in Patients with Human Immunodeficiency Virus Infection', The New England Journal of Medicine, 349/11: 1036-46. (Pubitemid 37087618)
22. Montague, S. and Porteous, N. L. (2012) 'The Case for Including Reach as a Key Element of Program Theory', Evaluation and Program Planning (in press) [Epub ahead of print].
23. Moses, H. and Martin, J. B. (2011) 'Biomedical Research and Health Advances', The New England Journal of Medicine, 10/364: 567-71.
24. OECD. (2010) OECD Reviews of Regional Innovation: Catalonia, Spain 2010. Paris, France: Organisation for Economic Co-Operation and Development (OECD).
25. Oortwijn, W. J. et al. (2008) 'Assessing the Impact of Health Technology Assessment in The Netherlands', International Journal of Technology Assessment in Health Care, 24/3: 259-69. (Pubitemid 351950161)
26. Panel on the return on investments in health research. (2010) Making and Impact. A preferred Framework and Indicators to Measure Returns on Investment in Health Research, (Ottawa, Canada: Canadian Academy of Health Science (CAHS), 2009) last accessed 13 September 2011.
27. Permanyer, M. G. et al. (2002) 'Características basales y determinantes de la evolución en pacientes ingresados por insuficiencia cardiaca en un hospital general', Revista Española de Cardiología, 55/6: 571-8.
28. Raftery, J. et al. (2009) 'Assessing the Impact of England's National Health Service R&D Health Technology Assessment Program Using the "Payback" Approach', International Journal of Technology Assessment in Health Care, 25/1: 1-5.
29. Solà-Morales, O. and Granados, A. (2009) 'Health Technology Assessment in Catalonia: An Overview of Past and Future Perspectives', International Journal of Technology Assessment in Health Care, 25(Suppl. 1), 88-93.
30. Solans, M. et al. (2010) Impacte de les convocatòries de recerca clínica i en serveis sanitaris en la presa de decisions informades i la capacitació. Visió dels investigadors. Barcelona: Agencia d'Informació, Avaluació i Qualitat en Salut, Servei Català de la Salut, Departament de Salut, Generalitat de Catalunya.
31. -. (2012) Past, present and future. Barcelona: Agència d'Informació, Avaluació i Qualitat en Salut, Departament de Salut, Generalitat de Catalunya.
32. Tassey, G. (2008) The Roles and Economic Impacts of Technology Infrastructure. Version 3. Gaithersburg, MD: National Institute of Standards and Technology.
33. Wooding, S. et al. (2011) Project Retrosight. Understanding the Returns from Cardiovascular and Stroke Research, The Policy Report (Cambridge, UK: RAND Europe) last accessed 13 September 2011.
34. Woolf, S. H. (2008) 'The Meaning of Translational Research and Why It Matters', The Journal of the American Medical Association, 299/2: 211-3.